Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

被引：5

作者：

Mastorino, Luca ^{[1
]}

Siliquini, Niccolo ^{[1
]}

Avallone, Gianluca ^{[1
]}

Ortoncelli, Michela ^{[1
]}

Quaglino, Pietro ^{[1
]}

Dapavo, Paolo ^{[1
]}

Ribero, Simone ^{[1
]}

机构：

[1] Univ Turin, Dermatol Sect, Dept Med Sci, Via Cherasco 23, Turin, Italy

来源：

DERMATOLOGY REPORTS | 2022年 / 14卷 / 03期

关键词：

Psoriasis; Guselkumab; Cancer; IL-23; Neoplasia; Biological therapy;

D O I：

10.4081/dr.2022.9282

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页数：2

相关论文

共 7 条

[1] IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review [J].

Bellinato, Francesco ;

Gisondi, Paolo ;

Maurelli, Martina ;

Girolomoni, Giampiero .

DERMATOLOGIC THERAPY, 2021, 34 (02)

[2] A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis [J].

Bilal, Jawad ;

Berlinberg, Adam ;

Bhattacharjee, Sandipan ;

Trost, Jaren ;

Bin Riaz, Irbaz ;

Kurtzman, Drew J. B. .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (06) :569-578

[3] New insights into the IL-12 and IL-23: From a molecular basis to clinical application in immune-mediated inflammation and cancers [J].

Chyuan, I-Tsu ;

Lai, Jenn-Haung .

BIOCHEMICAL PHARMACOLOGY, 2020, 175

[4]

Kahn JS, 2019, J DRUGS DERMATOL, V18, P387

[5]

Kamiya K, Eur J Dermatol

[6] EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations [J].

Nast, A. ;

Smith, C. ;

Spuls, P. I. ;

Avila Valle, G. ;

Bata-Csorgo, Z. ;

Boonen, H. ;

De Jong, E. ;

Garcia-Doval, I. ;

Gisondi, P. ;

Kaur-Knudsen, D. ;

Mahil, S. ;

Malkonen, T. ;

Maul, J. T. ;

Mburu, S. ;

Mrowietz, U. ;

Reich, K. ;

Remenyik, E. ;

Ronholt, K. M. ;

Sator, P. G. ;

Schmitt-Egenolf, M. ;

Sikora, M. ;

Stromer, K. ;

Sundnes, O. ;

Trigos, D. ;

Van der Kraaij, G. ;

Yawalkar, N. ;

Dressler, C. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) :281-317

[7] Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparatore-controlled VOYAGE 2 trial [J].

Reich, Kristian ;

Armstrong, April W. ;

Foley, Peter ;

Song, Michael ;

Wasfi, Yasmine ;

Randazzo, Bruce ;

Li, Shu ;

Shen, Y. -K. ;

Gordon, Kenneth B. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (03) :418-431